Delivery Order 75N95023D00025-75N95024F00001
- Not listed
- This is a one-year, $113,077 cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH)'s National Institute on Drug Abuse to CCS Associates, Inc., a woman-owned small business, for regulatory affairs support. The order is part of a larger indefinite delivery vehicle (IDV) that CCS Associates holds from NIH to provide regulatory affairs assistance through 2028. CCS Associates has extensive experience supporting pharmaceutical research, clinical trials, regulatory...
- The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $209,529 to CCS Associates, Inc., a woman-owned small business headquartered in San Jose, California, for regulatory preparation, review, and submission services associated with clinical trials under the NIDA Drug Supply Program. The contract period runs from March 27, 2026 through March 26, 2027, and is structured as a cost-plus-fixed-fee arrangement with no set-aside designation. CCS Associates specializes in...
- The National Institute on Drug Abuse (NIDA) awarded a $394.5K delivery order contract to CCS Associates, Inc., a woman-owned small business based in San Jose, California, for regulatory preparation, review, and submission support associated with clinical trials under the NIDA Drug Supply Program. The contract runs from April 1, 2025 through March 31, 2026 and is structured as a cost-plus-fixed-fee arrangement with no set-aside designation. CCS Associates specializes in regulatory affairs and...
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $375,748 purchase order for medical writing consulting services to CCS Associates, Inc., a woman-owned small business based in San Jose, California. The services will support various neuroscience drug development programs, including the Blueprint Neurotherapeutics Program, the NIH Helping to End Addiction Long-term (HEAL) Initiative, and the Early Phase Pain Investigation...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $495.8K labor-hour purchase order to CCS Associates, Inc., a woman-owned small business based in San Jose, California, for regulatory affairs consulting support services. The contract, set aside for small businesses and effective through September 2026, will be performed primarily in Rockville, Maryland, with occasional on-site work. Under the original solicitation, CCS Associates will provide...
- This is a delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to CCS Associates, Inc., a woman-owned small business. The $545,690.33 contract is for regulatory activities supporting PCCA and MMAB gene therapy products. The contract has a period of performance through May 20, 2028 and is a labor hours contract type. CCS Associates has previously secured several large Indefinite Delivery Vehicle (IDV) contracts with NCATS, the...
- This is a delivery order contract awarded to CCS Associates, Inc., a woman-owned small business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The $3,882,241.70 firm fixed price contract provides administrative support services to the NCI. CCS Associates has secured numerous federal contracts and grants to assist government agencies in advancing medical research and drug development...
- This $548,714.60 firm fixed-price delivery order contract was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to CCS Associates, Inc., a woman-owned small business. The contract is for TAS (Task Area Support) to provide strategic planning and activities support for NCI's Center for Strategic Scientific Initiatives (CSSI). CCS Associates specializes in providing comprehensive research support services to federal agencies,...
- This is a definitive contract awarded to CCS Associates, Inc., a woman-owned small business, by the Food and Drug Administration (FDA) for a quality assurance and quality improvement program to review clinical trials supported or funded by the FDA. The contract has a ceiling value of $87,620.95 and a period of performance that ends on March 29, 2019. It is a time and materials contract type. CCS Associates has received numerous federal contracts and grants, including several large indefinite...
- CCS Associates, Inc. was awarded a $461,849 purchase order by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to provide medical writing consulting and drug dossier development support services. The contract calls for the contractor to prepare regulatory documents and drug dossiers to support the Blueprint Neurotherapeutics Program, Early Phase Pain Investigation Clinical Network, and other NIH neuroscience research initiatives. Awarded...
- 75N95023D00025Indefinite Delivery Contract
- 75N95023D00025-75N95024F00001Delivery Order
This is a Delivery Order contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to CCS Associates, Inc., a woman-owned small business. The contract is for REGULATORY AFFAIRS SUPPORT services with a period of performance from April 1, 2024 to March 31, 2025 and a ceiling value of $307,737.00. This contract does not have a set-aside designation. CCS Associates is an experienced provider of research support services to federal agencies, particularly within the National Institutes of Health, and has secured numerous previous contract awards and grants for regulatory affairs, clinical trial management, and scientific consulting work. The company holds several significant Indefinite Delivery Vehicle (IDV) contracts with NIH institutes, including a $545 million IDV with the National Institute of Allergy and Infectious Diseases to provide comprehensive research support services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $93.5k | 11/22/24 | |
| P00001 | Exercise an Option | $93.5k | 8/21/24 | |
| Not listed | Not listed | $120.7k | 3/27/24 |